The Global Fund Board seeks new members for the Technical Review Panel

Author:

Download PDF Lancet Commission confirms malaria could be eradicated by 2050 In the first academic article of its kind, the Lancet Commission on Malaria Eradication report shows – by synthesizing existing evidence – that the world can achieve malaria eradication within a generation. The report overview highlights the progress made globally between 2000 and 2017, during which the rate of…

Article Type:

Article Number:

Lancet commission on malaria eradication; Global Fund focus on private sector partnerships

ABSTRACT This GFO’s ‘Of Interest’ highlights the report just published by the Lancet Commission on Malaria Eradication, the first peer-reviewed academic document attesting to the feasibility of global malaria eradication by 2050, and the Global Fund’s new publication series spotlighting private sector partnerships.

Lancet Commission confirms malaria could be eradicated by 2050

In the first academic article of its kind, the Lancet Commission on Malaria Eradication report shows – by synthesizing existing evidence – that the world can achieve malaria eradication within a generation. The report overview highlights the progress made globally between 2000 and 2017, during which the rate of malaria cases declined by 36% and deaths from malaria declined worldwide by 60%. Momentum has been building for decades, the report says, and more than half the world’s countries are no malaria-free (in 1900, nearly all of the world’s 200 or so countries had endemic malaria). Now, the Commission says, the world is capable of achieving a world free of malaria within a generation. Examining the major operational, biological, and financial challenges to eradicating malaria, the report identifies solutions that will enable the envisioned eradication by 2050.

The Commission, created in 2017 as a joint endeavour between The Lancet and the Global Health Group at the University of California San Francisco (UCSF), has published an array of report summaries (in English, Chinese, French and Spanish), policy briefs, technical briefs and and an advocacy and communications toolkit, along with the report.

One of the lead authors of the report, and co-chair of the Lancet Commission on Malaria Eradication, is Sir Richard Feachem, who was the Global Fund’s founding Executive Director, from 2002 to 2007.

Read the Lancet Commission’s full report…

Read the New York Times (Reuters) article on the report…

Read Time.com’s article on the report…

++++++++++

Global Fund’s new publication series highlights partnerships with private sector

Though the Global Fund has consistently engaged, grown and developed its relationships with the private sector – which has contributed a total of $2.7 billion to the Fund – since its creation, the launch on September 2 of a new publication series, ‘Focus on Private Sector Partnerships’, brings a fresh look at the wide variety of partnerships and types of support the private sector currently brings to the Global Fund partnership. The most successful and arguably highest-profile of these partnerships is Product (RED), the consumer marketing initiative started in 2006, which alone has contributed more than $600 million to the Global Fund to support HIV programs in Africa, through revenues raised through (RED)-branded product sales from iconic brands (Apple’s (RED) iPhone is one of the most recognizable).

But there are many more: Project Last Mile, Ecobank, Zenysis, IBM

dation, Takeda Pharmaceutical Company, Goodbye Malaria, and more.

Read the Global Fund’s full news release…

 

 

 

++++++++++